Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adjuvant Chemotherapy ± Chemoradiotherapy for Adenocarcinoma of the Pancreatic Head: Results of the Radiotherapy Random Assignment of NRG Oncology/RTOG 0848.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Moving beyond anatomy: the future of rectal cancer management is biologically-informed, response-adapted, and patient-centered.

Clinical and translational radiation oncology·2026
Same author

Dosimetric Predictors of Problematic Receptive Anal Intercourse After Prostate Radiation Therapy.

Advances in radiation oncology·2026
Same author

Does Radiation Boost Dose Affect Organ Preservation Rates? A Secondary Analysis of the Organ Preservation in Patients With Rectal Adenocarcinoma Trial.

International journal of radiation oncology, biology, physics·2026
Same author

The Impact of Lung and Heart Radiation Dose During Preoperative Chemoradiation on Overall Survival in Esophageal Cancer-A Post Hoc Analysis of CALGB 80803 (Alliance).

International journal of radiation oncology, biology, physics·2026
Same author

Dose-Volume Histogram Compendium of Dose Constraints for Treatment Planning: An ASTRO Consensus Paper.

Practical radiation oncology·2026

Related Experiment Video

Updated: Nov 3, 2025

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.5K

Mature Experiences Using Local Therapy for Oligometastases.

Leila T Tchelebi1, Karyn A Goodman2

  • 1Department of Radiation Oncology, Penn State College of Medicine, Hershey, PA.

Seminars in Radiation Oncology
|June 6, 2021
PubMed
Summary

The oligometastatic state, with limited metastases, offers a potentially curable window for cancer patients. Local therapies, including surgery and stereotactic ablative radiotherapy (SABR), are increasingly explored for treating limited metastatic disease.

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.7K
Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
07:44

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Published on: March 12, 2018

10.3K

Related Experiment Videos

Last Updated: Nov 3, 2025

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.5K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.7K
Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
07:44

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Published on: March 12, 2018

10.3K

Area of Science:

  • Oncology
  • Surgical Oncology
  • Radiation Oncology

Background:

  • Cancer is a complex, heterogeneous disease with varying metastatic potential.
  • The oligometastatic state represents an intermediate stage with a limited number of metastases, potentially amenable to curative treatment.
  • Historically, surgical resection of metastases, particularly in the liver from colorectal cancer, has shown success.

Purpose of the Study:

  • To review the established role of surgery in managing limited metastatic cancer.
  • To examine recent advancements in alternative local therapies, such as stereotactic ablative radiotherapy (SABR), for oligometastases.
  • To discuss current clinical trials investigating local treatment modalities for patients with limited metastatic burden.

Main Methods:

  • Literature review of surgical metastatectomy data.
  • Review of recent clinical experiences with SABR for oligometastatic disease.
  • Analysis of ongoing clinical trials focused on local therapies for limited metastatic cancer.

Main Results:

  • Surgical resection has a proven role in managing limited metastatic disease in select cases.
  • Stereotactic ablative radiotherapy (SABR) is emerging as a viable local treatment option for oligometastases.
  • Several clinical trials are actively evaluating the efficacy of various local therapies for limited metastatic cancer.

Conclusions:

  • The oligometastatic state presents a curable subset of metastatic cancer.
  • Both surgical metastatectomy and SABR are important local treatment strategies for limited metastatic disease.
  • Ongoing research and clinical trials are crucial for further defining the optimal management of oligometastatic cancer.